Nalls Sherbakoff Group’s Johnson & Johnson JNJ Stock Holding History

Nalls Sherbakoff Group’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$102K	Sell	403 -308	-43%	-$71.8K	0.07%	135
2026 Q1	$174K	Hold	711	–	–	0.13%	107
2025 Q4	$147K	Buy	711 +308	+76%	+$60.9K	0.11%	121
2025 Q3	$74.7K	Hold	403	–	–	0.05%	169
2025 Q2	$61.6K	Buy	403 +50	+14%	+$7.69K	0.04%	181
2025 Q1	$58.6K	Buy	+353	New	+$55.2K	0.05%	169
2023 Q4	$60K	Buy	383 +1	+0.3%	+$153	0.05%	153
2023 Q3	$59.6K	Sell	382 -105	-22%	-$17.3K	0.06%	144
2023 Q2	$75.5K	Sell	487 -118	-20%	-$19K	0.07%	132
2023 Q1	$92.8K	Buy	+605	New	+$97.7K	0.09%	118
2018 Q4	$400K	Buy	+3,102	New	+$433K	0.64%	33

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Nalls Sherbakoff Group's JNJ Position: Q2 2026 in Review

Nalls Sherbakoff Group reduced its Johnson & Johnson (JNJ) stake by 43% in Q2 2026, selling an estimated $71.8K and leaving 403 shares worth $102K. The position accounts for 0.07% of the portfolio, ranked #135.

Nalls Sherbakoff Group first reported a position in JNJ in Q4 2018 and has held it in 11 quarters since. The position peaked at $400K in Q4 2018. 4,698 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

Nalls Sherbakoff Group held 403 shares of Johnson & Johnson worth $102K as of Q2 2026.
Nalls Sherbakoff Group sold 308 Johnson & Johnson shares in Q2 2026, an estimated $71.8K.
Johnson & Johnson made up 0.07% of Nalls Sherbakoff Group's portfolio in Q2 2026, its #135 holding.
Nalls Sherbakoff Group first reported a position in Johnson & Johnson in Q4 2018 and has held it in 11 quarters since.
Nalls Sherbakoff Group's Johnson & Johnson position peaked at $400K in Q4 2018.
4,698 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Nalls Sherbakoff Group's 13F filing for Q2 2026, filed 17 Aug 2026.